emails

PATH Study User Feedback Survey Dissemination Plan

Brief Description of the Dissemination Task:

PATH Study User Feedback Survey

Audience: Tobacco research community familiar with the PATH Study data, including external researchers and Federal staff at NIH, FDA, CDC, and other agencies.

Purpose: To invite audience to complete the PATH Study User Feedback survey.

Communication Strategy:

1. NAHDAP will send an email to current and former PATH Study data users maintained in their database, including users who participated in the past PATH summer workshops. NAHDAP will also update the ICPSR PATH Study series webpage.

2. CTP’s PATH Study Branch and the NIDA PATH Study Team will implement outreach via listservs.

   1. Center for Coordination of Analytics, Science, Enhancement, and Logistics in Tobacco Regulatory Science (CASEL)

   2. FDA/ Center for Tobacco Products (CTP) social media

   3. Society for Research on Nicotine & Tobacco (SRNT) listservs

   4. College on Problems of Drug Dependence (CPDD) listserv

   5. The NIH Tobacco and Nicotine Research Interest Group (TANRIG) listserv

1. FOR REVIEW: Draft Survey Invitation Email for PATH Study Data Users from ICPSR/NAHDAP’s email database

Subject: Feedback Requested - Population Assessment of Tobacco and Health (PATH) Study

Dear PATH Study research community,

The FDA’s Center for Tobacco Products (CTP) and the NIH’s National Institute on Drug Abuse (NIDA) invites you to share your experiences or plans in using the Population Assessment of Tobacco and Health (PATH) Study data.

As a reminder, the PATH Study is a household-based, nationally representative, longitudinal cohort study of youth (12-17 years old) and adults in the United States. The study was launched in 2011 to inform FDA’s regulatory activities under the Family Smoking Prevention and Tobacco Control Act.

The survey will take no longer than 15 minutes. Your answers will inform us on how to make your experience with the data even better.

Click here to start the survey.

Thank you in advance for your valuable insights and your time. For any questions, please contact [email protected].

Thank you very much,

[insert sender closing here].

2. FOR REVIEW: Draft Survey Invitation Email for Listservs

Subject: Feedback Requested - Population Assessment of Tobacco and Health (PATH) Study

Have you ever used the PATH Study data or heard about it? If so, we would like to hear from you! The FDA’s Center for Tobacco Products (CTP) and the NIH’s National Institute on Drug Abuse (NIDA) would like to invite you to share your experiences in using the PATH Study data.

As a reminder, the PATH Study is a household-based, nationally representative, longitudinal cohort study of youth (12-17 years old) and adults in the United States. The study was launched in 2011 to inform FDA’s regulatory activities under the Family Smoking Prevention and Tobacco Control Act.

The survey will take no longer than 15 minutes, and your answers will inform us on how to make your experience using the data even better.

Click here to start the survey.

Thank you in advance for your valuable insights and your time. For any questions, please contact [email protected].

Thank you,

[insert sender closing here]

.

3. FOR REVIEW: Draft Survey Follow-up Email

Subject: There’s still time to provide feedback on the Population Assessment of Tobacco and Health (PATH) Study data!

The FDA’s Center for Tobacco Products (CTP) and the NIH’s National Institute on Drug Abuse (NIDA) still want to hear from you about your experiences in using the PATH Study data!

As a reminder, the PATH Study is a household-based, nationally representative, longitudinal cohort study of youth (12-17 years old) and adults in the United States. The study was launched in 2011 to inform FDA’s regulatory activities under the Family Smoking Prevention and Tobacco Control Act.

Click here to start the survey.

This survey will take no longer than 15 minutes to complete and will be open until xx/xx/2021.

Thank you in advance for your valuable insights and your time. For any questions, please contact [email protected].

Thank you,

[insert sender closing here]

4. FOR REVIEW: PATH Study Update Tweets

@FDA and @NIH Population Assessment of Tobacco and Health (PATH) Study is interested in getting your feedback in using the PATH Study data. Find survey here.

The PATH study is a large, long-term study that monitors and assesses outcomes associated with tobacco use in the U.S. https://doi.org/10.3886/Series606 (259 characters)

5. FOR REVIEW: NAHDAP PATH Study Series Webpage

The FDA’s Center for Tobacco Products (CTP) and the NIH’s National Institute on Drug Abuse (NIDA) is interested in getting your feedback in using the PATH Study data. Complete survey here.